N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B

US7973166B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Matthias Schneider · Dossenheim, DE
• Michael Gottfried · Wuppertal, DE
• Jens Geisler · Berlin, DE
• Gabriele Winter · Lübbenau/Spreewald - Lubnjow/Błota, DE

Key dates

• Filing date: Aug 28, 2009
• Grant date: Jul 5, 2011
• Expiry date: Dec 16, 2029

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The crystalline Polymorph B of N-(2-aminophenyl)-4-[N-(pyridine-3-yl)methoxy-carbonyaminomethyl]benzamide (MS-275) of formula Iis described, as well as the process for the production of said compound, and its use as a medicament for the treatment of selected diseases.